key: cord-0691543-7d4l7zyt
authors: Blayney, Michael C.; Stewart, Neil I.; Kaye, Callum T.; Puxty, Kathryn; Chan Seem, Robert; Donaldson, Lorraine; Haddow, Catriona; Hall, Ros; Martin, Caroline; Paton, Martin; Lone, Nazir I.; McPeake, Joanne
title: Prevalence, characteristics and longer-term outcomes of patients with persistent critical illness due to COVID-19 in Scotland: a national cohort study
date: 2022-03-24
journal: Br J Anaesth
DOI: 10.1016/j.bja.2022.03.017
sha: 1a4701f832e9d5b34082cae107a4d3b4fc6bdb94
doc_id: 691543
cord_uid: 7d4l7zyt

BACKGROUND: Patients with coronavirus disease (COVID-19) can require critical care for prolonged periods. Patients with Persistent Critical Illness can have complex recovery trajectories but this has not been researched for patients with COVID-19. We examined the prevalence, risk factors and long-term outcomes of critically ill COVID-19 patients with persistent critical illness. METHODS: A national cohort study of all adults admitted to Scottish critical care units with COVID-19 from 01/03/20 to 04/09/21. Persistent critical illness was defined as a critical care length of stay (LOS) of ≥10 days. Outcomes included one-year mortality and hospital readmission following critical care discharge. Fine and Gray competing risk analysis was used to identify factors associated with Persistent Critical Illness with death as a competing risk. RESULTS: 2236 patients with COVID-19 were admitted to critical care. 1045 patients were identified as developing Persistent Critical Illness, comprising 46.7% of the cohort but using 80.6% of bed-days. Persistent Critical Illness patients used more organ support, had longer post-critical care LOS and longer total hospital LOS. Persistent critical illness was not significantly associated with long-term mortality or hospital readmission. Risk factors associated with increased hazard of Persistent Critical Illness include age, illness severity, organ support on admission and fewer comorbidities. CONCLUSION: Almost half of all critical care patients with COVID-19 develop persistent critical illness, with high resource use in critical care and beyond. However, persistent critical illness was not associated with a significantly worse long-term outcomes compared to patients who were critically ill for shorter periods.

Patients with coronavirus disease can require critical care for prolonged periods. Patients with Persistent Critical Illness can have complex recovery trajectories but this has not been researched for patients with COVID-19. This study aims to examine prevalence, risk factors and long-term outcomes of critically ill COVID-19 patients with Persistent Critical Illness.

A national cohort study of all adults admitted to Scottish critical care units with COVID-19 from 01/03/20-04/09/21. Persistent Critical Illness was defined as a critical care length of stay (LOS) of ≥10 days. Outcomes included one-year mortality and hospital readmission following critical care discharge. Fine and Gray competing risk analysis was used to identify factors associated with Persistent Critical Illness with death as a competing risk.

2236 patients with COVID-19 were admitted to critical care. 1045 patients were identified as developing Persistent Critical Illness, comprising 46.7% of the cohort but using 80.6% of bed-days.

Persistent Critical Illness patients used more organ support, had longer post-critical care LOS and longer total hospital LOS. Persistent Critical Illness was not significantly associated with long-term mortality or hospital readmission. Risk factors associated with increased hazard of Persistent Critical Illness include age, illness severity, organ support on admission and fewer comorbidities.

Coronavirus disease 2019 , caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was declared a global pandemic in March 2020 by the World Health Organisation 1 . The related severe acute hypoxemic respiratory failure which severe COVID-19 infection may cause, often necessitates admission to an intensive care unit (ICU) for mechanical ventilation and multi-organ support 2 . Evidence is emerging internationally on the clinical characteristics of those patients admitted to ICU due to COVID-19 [3] [4] . These data have shown that these patients often have a high severity of illness, requiring extended ICU stays and high resource use 5 .

Previous research has characterised the 'Persistent Critical Illness' cohort, a patient group with extended ICU stays and high hospital resource use, often followed with complicated recovery trajectories [6] [7] [8] [9] [10] . For example, in a 14-year national cohort study in Australia and New Zealand found the Persistent Critical Illness cohort accounted for 5.0% of the patients admitted to ICU, but almost a third of ICU bed-days 9 . Limited data exist regarding the Persistent Critical Illness cohort in the context of the COVID-19 pandemic, especially in relation to longer-term outcomes and ongoing resource use.

A greater understanding of Persistent Critical Illness prevalence in COVID-19 patients may be helpful to guide decisions around resource allocation and rehabilitation needs. Therefore, this complete prospective national cohort study has two aims. Firstly, examine the profile, prevalence and outcomes of patients admitted to critical care who develop Persistent Critical Illness. 

Exposure: The primary exposure of interest was Persistent Critical Illness, defined as a length of stay in critical care of at least 10 days duration, consistent with literature relating to a pan-ICU population [9] [10] . However, the clinical course of patients admitted to critical care with COVID-19 is still evolving.

Indeed, data has demonstrated that the clinical course and case-mix of critically ill COVID-19 patients is changing across different 'waves' of the pandemic 12, 13 . Furthermore, previous work has demonstrated that the focus of clinical care for ICU patients may differ from those remaining in ICUs beyond 21 days, regardless of their diagnosis 8 . Thus, to ensure an inclusive definition, we utilised a 21-day cut-off point to define Persistent Critical Illness in a sensitivity analysis.

Outcomes: Outcomes included mortality (at critical care discharge and hospital discharge), critical care interventions (type/duration of organ support during critical care stay), resource use (duration of critical care and post-critical care hospital stay (for critical care survivors)) and post-critical care J o u r n a l P r e -p r o o f outcomes (post-critical care mortality and post-hospital discharge hospital readmission risk). Critical care outcomes were available for those had been discharged or died on or before 25/09/2021.

Other variables: Demographic variables were sex, age and ethnicity. Ethnicity was derived from categories of the Scottish Census 2011 with low frequencies aggregated 14 . Socioeconomic deprivation was defined using quintiles of the Scottish Index of Multiple Deprivation (SIMD Version 2020) 15 . SIMD is an area-based ranking index based on postcode of residence. Previous health status comprised the number of emergency acute hospital admissions in the year before admission, Clinical Frailty Score, and comorbidities. SICSAG-defined severe comorbidities were combined with Charlson-defined comorbidities as previously described [16] [17] and represented as individual comorbidities for the most prevalent comorbidities, and a count. Acute illness variables comprised duration from hospital admission to critical care admission, PaO2:FiO2 (PF) ratio, the Acute Physiology Score (APS) of the APACHE II model (grouped as tertiles) and number of organ systems supported at critical care admission (cardiovascular, respiratory and renal support).

Baseline characteristics and outcomes were stratified in tables by exposure status (Persistent Critical Illness vs Discharged alive before day 10 vs Died before day 10), and outcomes were compared using chi-square, Kruskal Wallis and log-rank tests. Daily frequency of bed occupancy and organ support activity was derived from Augmented Care Period (ACP) data and presented stratified by exposure status 11, 12, 16 .

Univariable and multivariable associations of patient characteristics with development of Persistent Critical Illness as an outcome were assessed using Fine and Gray competing risk analysis 18 , using death before 10 days as a competing risk to help control for survivor bias. Due to its non-linear association with outcomes, age was categorised into easily interpretable and similarly sized groups. Comorbidity counts were used in preference to individual comorbidities to reduce degrees of freedom of the models.

A Kaplan-Meier plot was presented for the cohort who survived to critical care discharge to explore post-critical care survival stratified by those who spent at least 10 days in critical care versus those who were discharged before 10 days. A Cumulative incidence plot was presented for those who survived to hospital discharge to explore emergency hospital readmission, stratified by those who spent at least 10 days in critical care versus those who were discharged before 10 days. Maximum follow-up was truncated to 1 year, as data were sparse beyond this. One-year outcomes for both postcritical care survival and emergency hospital readmission were presented using these methods. Risk factors associated with survival following critical care discharge were investigated using Cox regression J o u r n a l P r e -p r o o f in univariable and multivariable models. Risk factors associated with emergency hospital readmission following hospital discharge were investigated using Fine and Gray competing risk analysis, with death following hospital discharge as a competing risk.

We repeated Fine and Gray competing risk models identifying risk factors associated with developing Persistent Critical Illness, where Persistent Critical Illness was redefined as a critical care stay of at least 21 days as explained above.

Data were analysed using R Version 3.6.1 19 

The funder had no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.

Between 01/03/2020 and 04/09/2021, 2236 patients with laboratory confirmed COVID-19 were admitted to 24 ICUs across Scotland. Baseline demographic and clinical characteristics, stratified by Persistent Critical Illness status, are presented in Table 1 . 23 patients remained in critical care units on the censor date (e- Table 1 ). Figure 1 shows cohort derivation and flow.

There were 1045 patients with Persistent Critical Illness, representing 46.7% of all admissions. Median age was 59 years (IQR 51, 67) and differed by exposure status: Discharged before 10 days 56 (45,64), Died before 10 days 64 (57,72), and Persistent Critical Illness 60 (52,67). There was a greater proportion of patients living in more deprived neighbourhoods in the Persistent Critical Illness cohort (31.1% most deprived, 12.8% least deprived) compared to the cohort who were discharged before 10 days (25.5% most deprived, 12.3% least deprived).

Almost two thirds of patients overall had no comorbidities (63.4%). The most common comorbidities were respiratory disease (12.3%) and diabetes (11.6%). Comorbidities were more frequent in the group who died before 10 days (55.8%) compared to those discharged before 10 days (44.0%) and

Persistent Critical Illness (42.5%) cohorts. Additionally, a smaller proportion of the Persistent Critical Illness cohort had multiple comorbidities (12.8% vs 15.5% in those who were discharged before 10 days and 30.3% in those who died before 10 days). More than three quarters (76.9%) of patients had no emergency admissions in the preceding year. Most patients overall were non-frail (61.1%), although 24.8% were missing frailty data. The proportion of non-frail patients was similar in the Persistent Critical Illness (62.3%) and discharged before 10 days cohorts (66.7%). Those who died before 10 days were less likely to be non-frail (43.3%).

Most patients had one organ system supported on critical care admission (56.9%). Multiorgan support was more frequent in the Persistent Critical Illness (41.2%) and died before 10 days (46.9%) cohorts compared to those discharged before 10 days (14.9%). Advanced respiratory support was required on admission in less than half of patients overall (42.3%), but was more common in the Persistent Critical Illness (56.7%) and died before 10 days (54.9%) cohorts, compared to those discharged before 10 days Overall, 761 patients (34.0%) died before critical care discharge and 848 (37.9%) patients died before ultimate hospital discharge (Table 2 ). Mortality following critical care discharge but prior to hospital discharge was lower in Persistent Critical Illness patients compared with patients discharged from critical care before 10 days (2.4% vs 4.9%). Measured after critical care discharge, 1-year mortality was low in both groups (Persistent Critical Illness 6.6%(CI 4.3%,8.9%) vs Discharged before 10 days J o u r n a l P r e -p r o o f 9.5%(7.5%,11.5%)) ( Figure 3A ). For the cohort who survived to critical care discharge, factors associated with mortality following critical care discharge are presented in e- Figure 3B ). Factors associated with readmission are presented in e- Table 3 . After confounder adjustment, there was no significant association between Persistent Critical Illness and hospital readmission (HR 1.31 (0.99,1.73),p=0.055).

In univariable models, several patient characteristics were associated with Persistent Critical Illness status (Table 3) cohorts 17, 24 . We hypothesise that these differences may be partly driven by the higher mortality in patients with multimorbidity and pre-existing poor health in the short stay COVID-19 cohorts. Complex multimorbidity is known to negatively impact both short and long-term outcomes from critical care [25] [26] . Research examining the interplay between COVID-19 and pre-existing comorbidities is urgently required in order to understand optimal management for these patients.

Persistent Critical Illness patients have complex needs which often required specialist interventions, especially in relation to communication and rehabilitation, both during the critical care stay and after discharge 27 . These adaptations to care are crucial to ensure optimal outcomes and experience. Due to the demanding workload and the challenges which critical care staffing experienced during the pandemic, many of these adaptations may not have been routinely adopted 28 . Additionally, family caregivers had limited access during the pandemic to patient visiting and bedside clinician updates. As such, both patients, and family caregivers, may have complex challenges following hospital discharge.

These challenges, and the burdens associated with Persistent Critical Illness, are not captured when assessing survival following critical care discharge 29 . Future research should focus on the ongoing symptomatology suffered by these patients and their caregivers, the impact of post-critical care interventions to address these rehabilitation needs, and how this may differ from other critical care patients. Clinicians should also strive to understand the impact of the pandemic on families and how this can be mitigated in future waves.

This study has several strengths. Firstly, by linking multiple datasets of routinely collected data, we are confident that we have complete outcome data and high percentage of organ support data so can make a good assessment of the link between critical care and outcome. By linking with the ECOSS database, which records all patients with a positive COVID-19 polymerase chain reaction swab, we are confident that all patients in the cohort were suffering from confirmed COVID-19 disease. Additionally, by including variables such as socioeconomic status in the logistic regression we were able to identify more holistic variables associated with long critical care stay than other datasets may be able to provide. Our analyses allowed for the competing risk of death to be evaluated in associations such as the non-linear relationship between age and Persistent Critical Illness.

There are a number of potential limitations with this study. Firstly, due to the changes in service provision during the pandemic, some patients which usually would have been cared for in an HDU environment, may have received additional respiratory support outside traditional critical care areas and therefore do not contribute to our dataset. This may result in some under reporting regarding the duration of organ support or critical care stay in our patients. Additionally, the routine data collected did not take into account any of the potential disease modifying agents which were identified as the pandemic developed, such as Dexamethasone and Tocilizumab. Although there is evidence to suggest they decrease mortality in patients with COVID-19, our study is unable to identify if they have any impact on the development or duration of Persistent Critical Illness. Finally, our reporting of ethnicity J o u r n a l P r e -p r o o f 13 data is relatively restricted due to the small numbers of non-white patients and aggregate reporting requirements for small groups. Additionally, within this relatively small population, there were a number of patients with unknown ethnicity, therefore further weakening the confidence in any assessment of the impact of ethnicity.

Almost half of patients admitted to critical care in Scotland with COVID-19 developed persisting critical illness. This group of patients used more than four fifths of all bed-days occupied by patients with COVID-19 and used more post-critical care and post-hospital discharge resource, but had better longterm mortality. Clinical services need to continue to develop to meet the substantial care needs for this group of patients and their families.

Authors' contributions, transparency statement and data access NL affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained. NL, JM, NS, MB, CK and KP contributed to conception and design of the work. All authors contributed to data acquisition or analysis. All authors contributed to interpretation of data for the work. NL, JM, NS, MB, CK and KP drafted the work. All authors revised it critically for important intellectual content. All authors gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Since analyses involved data on unconsented participants, we are unable to share individual level data. 

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom

Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Hospital-level variation in the development of persistent critical illness

Functional Outcomes, Goals, and Goal Attainment Amongst Chronically Critically Ill Long-Term Acute Care Hospital Patients

Prolonged mechanical ventilation in critically ill patients: epidemiology, outcomes and modelling the potential cost consequences of establishing a regional weaning unit

Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study

Timing of onset of persistent critical illness: a multicentre retrospective cohort study

Intensive Care Society Audit Group Annual Report: Audit of Intensive Care Units in Scotland

SICSAG. Scottish Intensive Care Society Audit Group Report on COVID-19 as at 10

National Records of Scotland. Scotland's Census: Ethnic group

Scottish Index of Multiple Deprivation 2020

Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study

Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care

A Proportional Hazards Model for the Subdistribution of a Competing Risk

R: A language and environment for Statistical Computing

Patient-and family-centered performance measures focused on actionable processes of care for persistent and chronic critical illness: protocol for a systematic review

Impact of frailty on persistent critical illness: a population-based cohort study

Timing of Onset, Burden, and Postdischarge Mortality of Persistent Critical Illness in Scotland

Timing and burden of persistent critical illness in UK intensive care units: an observational cohort study

Hospital readmission after critical care survival: a systematic review and meta-analysis

Multimorbidity and its relationship with long-term outcomes following critical care discharge: a prospective cohort study

Determinants of Health-Related Quality of Life After ICU: Importance of Patient Demographics, Previous Comorbidity, and Severity of Illness

Patient and Family Centered Actionable Processes of Care and Performance Measures for Persistent and Chronic Critical Illness: A Systematic Review

How the COVID-19 pandemic will change the future of critical care

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care

We thank all the clinicians in the Scottish ICUs who contributed data to the Scottish Intensive Care Society Audit Group registry (SICSAG).

All authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; NL is Director of Research, Intensive Care Society; JM is funded by a THIS.Institute (University of Cambridge) Research Fellowship (PD-2019-02-16). The funder had no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.